These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. Gallowitsch HJ, Mikosch P, Kresnik E, Unterweger O, Gomez I, Lind P. J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591 [Abstract] [Full Text] [Related]
3. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I. J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515 [Abstract] [Full Text] [Related]
4. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases. Nishiyama Y, Yamamoto Y, Ono Y, Takahashi K, Nakano S, Satoh K, Ohkawa M, Tanabe M. Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332 [Abstract] [Full Text] [Related]
5. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma. Alam MS, Takeuchi R, Kasagi K, Misaki T, Miyamoto S, Iida Y, Hidaka A, Konishi J. Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573 [Abstract] [Full Text] [Related]